Asuragen, Inc. Launches Powerful New microRNA Analysis Tool
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular biology service provider and oncology molecular diagnostic company, announced today the launch of its new high-content microRNA (miRNA) service. The service enables comprehensive analysis of miRNA expression profiles from published miRNA sequences and a vastly expanded set of unpublished candidate miRNAs.